Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant genetic condition, caused by mutations in the adenomatous polyposis coli APC tumor suppressor gene. Desmoid tumors (DTs) are seen in 15% to 20% of FAP patients. Specific location of mutation serves as a guide to predict colonic and extra colonic manifestations and their aggressiveness. A severe FAP-phenotypic family was registered in a genetic counselling high-risk Uruguayan hereditary cancer clinic. Proband's DNA was analysed by NGS, detecting a pathogenic mutation in APC gene. All willing family members were counselled and encouraged to be tested. Here we report a kindred formed by 16 individuals with a very severe FAP phenotype. A two-base deletion mutation: c.4393_4394delAG in APC gene and a consequent premature stop codon was detected. DTs were diagnosed in 6 individuals, ranging from 2 to 25 years of age. The causes of death were diverse: gastric cancer, rectal cancer and desmoid tumor. The already described genotype-phenotype correlation has proved its worth in this family, as clinical features reflect the mutation location at 3' end of gene. The inheritable and lethal nature of the disease needs a tailored follow up approach in order to reduce mortality, optimize local tumor control, and preserve patients' quality of life.

The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor

“…Environmental factors are also thought to contribute to the variation in clinical features [3]. There is some phenotypic diversity in FAP patients, including thyroid cancer [4], hepatoblastoma [5], desmoid tumor [6], epidermoid cysts, and osteomata [7]. So, it is means that the APC mutation is observed in patients, who also frequently show simultaneous tumors at different sites, suggesting that APC is responsible for maintaining the normal epithelium growth in body.…”